The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...
The FDA approved Ozempic to treat kidney disease in Type 2 diabetes patients after trials showed it reduces the risk of ...
12h
The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...
The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...
Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...
The term "blue chip" originated from poker, where blue chips were the highest denomination of chips used in the game.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback